Buying guide
Pixel Watch vs Stelo in 2026
Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.
Key differences
- Pixel Watch has more capabilities independently verified as autonomous (1 vs 0).
- Stelo has the lower recorded price.
- Stelo has more verified real-world deployments (1 vs 0).
| Attribute | ||
|---|---|---|
| Manufacturer | Dexcom | |
| Form factor | biometric | biometric |
| Maturity | commercial | commercial |
| Autonomy | ✓ 1 verified autonomous | — |
| Availability | shipping-nowshipping | shipping-nowshipping |
| Price | $349-$399 (actual sale price) | $89-$99 (actual sale price) |
| Capability claims |
| — |
| Brain | — | — |
| Verified deployments | 0 | 1Global |
| Privacy practices | 11cloud-upload, data-deletion-control, data-sale, data-retention, location-tracking, third-party-sharing, biometric-storage, biometric-storage, data-sale, data-deletion-control, data-retention | 4biometric-storage, training-data-use, third-party-sharing, data-deletion-control |
| Sources on file | 17 | 11 |
Editorial summaries
Pixel Watch
The Google Pixel Watch (current hardware the Pixel Watch 4, October 2025; the Pixel Watch 3 remains supported) is a biometric-primary smartwatch and the first-of-kind-cleared archetype of the cohort. Its sensors (multipath PPG heart rate, ECG via crown and caseback, SpO2, skin temperature, accelerometer) drive HRV, breathing rate, and resting heart rate, on Fitbit and Google Health algorithms (Google owns Fitbit). It is a hardware purchase (about $349 for the 41mm aluminum, $399 for the 45mm, plus about $100 for LTE), with an optional Google Health Premium subscription ($9.99/month) that gates the Sleep Profile and the Gemini AI coach. DEPLOY records commercial maturity. Its standout verified achievement is loss-of-pulse detection, which received an FDA De Novo authorization in February 2025, a first-of-kind clearance for cardiac-event detection on a consumer watch; the cleared indication is specific and should not be read as a general cardiac-diagnostic claim. Google's broader biometric strategy also spans Fitbit (Charge, Sense, Versa).
Stelo
Dexcom's Stelo is the first-ever FDA-cleared over-the-counter (no-prescription) glucose biosensor (De Novo, March 5, 2024; US launch August 26, 2024): a 15-day continuous glucose monitor for adults 18+ not on insulin (type 2 not on insulin, plus non-diabetic users tracking how diet and exercise affect glucose). It is the generative-AI end of the glucose cell: Weekly Insights run on Google Cloud's Vertex AI and Gemini, with AI photo meal-logging and personalized daily recommendations, the AI substance that carries it across the biometric boundary. Pricing is about $89 for a 2-week sensor on a biweekly subscription model (around $99/month). From DexCom (NASDAQ: DXCM), Stelo is the OTC product line, separate from the prescription G7. Cap-flag: the cleared indication is an OTC CGM for adults 18+ not on insulin; it is explicitly NOT cleared for problematic hypoglycemia and has no low-glucose alerts, so it should not be read as a diabetes-management device.
Common questions
- What is the difference between Pixel Watch and Stelo?
- Pixel Watch and Stelo are both biometric robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.
- Which is cheaper, Pixel Watch or Stelo?
- Stelo has the lower recorded price on the DEPLOY registry than Pixel Watch. Prices are sourced; see each record for whether the figure is a manufacturer target, an estimate, or an actual sale price.
- Is Pixel Watch or Stelo more autonomous?
- Pixel Watch has more capabilities independently verified as autonomous on the DEPLOY registry than Stelo. DEPLOY counts a capability as autonomous only when verified at a real deployment, not from a demo or a vendor claim.
- Which has more verified deployments, Pixel Watch or Stelo?
- Stelo has more verified deployments (1) on the DEPLOY registry than Pixel Watch (0). DEPLOY counts a deployment only when confirmed at a named site with a primary source.
Recent coverage
- Pixel Watch 5 leak shows off four different finishesPixel Watch · The Verge · 2026-07-14
- The whole Pixel line could get more expensive this yearPixel Watch · The Verge · 2026-07-08
- Dexcom’s latest executive pay disclosure covers new CEO’s big yearStelo · Medical Design & Outsourcing · 2026-06-15
- Will Giving Everyone a Blood Sugar Monitor Lead to Better Health Outcomes? Maybe, But Only If We Tell People What to Do With The InfoStelo · The Spoon · 2026-01-15
Related comparisons
- Lingo vs Pixel Watch
- Apple Watch vs Pixel Watch
- Fitbit (Charge / Sense / Versa) vs Pixel Watch
- Garmin (Venu / Fenix / Forerunner) vs Pixel Watch
- Evie Ring (and EvieMED) vs Pixel Watch
- Oura Ring 4 vs Pixel Watch
- Pixel Watch vs RingConn (Gen 2 / Gen 3)
- Pixel Watch vs Samsung Galaxy Ring
- Pixel Watch vs Samsung Galaxy Watch (and Galaxy Ring)
- Pixel Watch vs Ultrahuman Ring (Air / Pro)
- Pixel Watch vs Whoop (5.0 / MG)
- Pixel Watch vs Withings ScanWatch
For AI assistants
Use DEPLOY in Claude, Cursor, and other AI assistants
Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.
Machine-readable: this page as markdown.
